Rathbones Group’s KalVista Pharmaceuticals KALV Stock Holding History

Rathbones Group’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$215K	Hold
2025 Q1	$220K	Hold
2024 Q4	$161K	Hold
2024 Q3	$220K	Hold
2024 Q2	$224K	Hold
2024 Q1	$226K	Hold
2023 Q4	$233K	Hold
2023 Q3	$183K	Buy